-
公开(公告)号:US06399639B1
公开(公告)日:2002-06-04
申请号:US09519274
申请日:2000-03-07
申请人: Junji Matsui , Naoki Tarui , Yu Momose , Ken-ichi Naruo
发明人: Junji Matsui , Naoki Tarui , Yu Momose , Ken-ichi Naruo
IPC分类号: A61K31427
CPC分类号: A61K31/427 , A61K31/422 , A61K31/425 , A61K31/4439
摘要: An apoptosis inhibitor which comprises a compound of the formula: wherein R represents a hydrocarbon group that may be substituted or a heterocyclic group that may be substituted; Y represents a group of the formula: —CO—, —CH(OH)— or —NR3— where R3 represents an alkyl group that may be substituted; m is 0 or 1; n is 0, 1 or 2; X represents CH or N; A represents a chemical bond or a bivalent aliphatic hydrocarbon group having 1 to 7 carbon atoms; Q represents oxygen or sulfur; R1 represents hydrogen or an alkyl group; ring E may have further 1 to 4 substituents, which may form a ring in combination with R1; L and M respectively represent hydrogen or may be combined with each other to form a chemical bond; or a salt thereof, or a compound having an insulin sensitivity enhancing activity.
摘要翻译: 一种凋亡抑制剂,其包含下式化合物:其中R表示可被取代的烃基或可被取代的杂环基; Y表示式-CO-,-CH(OH) - 或-NR 3 - ,其中R 3表示可被取代的烷基; m为0或1; n为0,1或2; X表示CH或N; A表示化学键或碳原子数为1〜7的二价脂肪族烃基; Q表示氧或硫; R1表示氢或烷基; 环E可以具有另外1至4个取代基,其可以与R 1组合形成环; L和M分别表示氢或可以相互结合形成化学键; 或其盐,或具有胰岛素敏感性增强活性的化合物。
-
公开(公告)号:US06555565B2
公开(公告)日:2003-04-29
申请号:US10047816
申请日:2002-01-15
申请人: Junji Matsui , Naoki Tarui , Yu Momose , Ken-ichi Naruo
发明人: Junji Matsui , Naoki Tarui , Yu Momose , Ken-ichi Naruo
IPC分类号: A61K31427
CPC分类号: A61K31/427 , A61K31/422 , A61K31/425 , A61K31/4439
摘要: An apoptosis inhibitor which comprises a compound of the formula: wherein R represents a hydrocarbon group that may be substituted or a heterocyclic group that may be substituted; Y represents a group of the formula: —CO—, —CH(OH)— or —NR3— where R3 represents an alkyl group that may be substituted; m is 0 or 1; n is 0, 1 or 2; X represents CH or N; A represents a chemical bond or a bivalent aliphatic hydrocarbon group having 1 to 7 carbon atoms; Q represents oxygen or sulfur; R1 represents hydrogen or an alkyl group; ring E may have further 1 to 4 substituents, which may form a ring in combination with R1; L and M respectively represent hydrogen or may be combined with each other to form a chemical bond; or a salt thereof, or a compound having an insulin sensitivity enhancing activity.
-
公开(公告)号:US6087384A
公开(公告)日:2000-07-11
申请号:US272747
申请日:1999-03-15
申请人: Junji Matsui , Naoki Tarui , Yu Momose , Ken-ichi Naruo
发明人: Junji Matsui , Naoki Tarui , Yu Momose , Ken-ichi Naruo
IPC分类号: A61K31/422 , A61K31/425 , A61K31/427 , A61K31/4439 , A61K31/444 , C07D413/02 , C07D413/14 , C07D417/02 , C07D417/14 , A01K31/426 , A01K31/427
CPC分类号: A61K31/427 , A61K31/422 , A61K31/425 , A61K31/4439
摘要: An apoptosis inhibitor which comprises a compound of the formula: wherein R represents a hydrocarbon group that may be substituted or a heterocyclic group that may be substituted; Y represents a group of the formula: --CO--, --CH(OH)-- or --NR.sup.3 -- where R.sup.3 represents an alkyl group that may be substituted; m is 0 or 1; n is 0, 1 or 2; X represents CH or N; A represents a chemical bond or a bivalent aliphatic hydrocarbon group having 1 to 7 carbon atoms; Q represents oxygen or sulfur; R.sup.1 represents hydrogen or an alkyl group; ring E may have further 1 to 4 substituents, which may form a ring in combination with R.sup.1 ; L and M respectively represent hydrogen or may be combined with each other to form a chemical bond; or a salt thereof, or a compound having an insulin sensitivity enhancing activity.
摘要翻译: 一种凋亡抑制剂,其包含下式化合物:其中R表示可被取代的烃基或可被取代的杂环基; Y表示式-CO-,-CH(OH) - 或-NR 3 - ,其中R 3表示可被取代的烷基; m为0或1; n为0,1或2; X表示CH或N; A表示化学键或碳原子数为1〜7的二价脂肪族烃基; Q表示氧或硫; R1表示氢或烷基; 环E可以具有另外1至4个取代基,其可以与R 1组合形成环; L和M分别表示氢或可以相互结合形成化学键; 或其盐,或具有胰岛素敏感性增强活性的化合物。
-
公开(公告)号:US5804601A
公开(公告)日:1998-09-08
申请号:US629623
申请日:1996-04-09
申请人: Kaneyoshi Kato , Shokyo Miki , Ken-ichi Naruo , Hideki Takahashi
发明人: Kaneyoshi Kato , Shokyo Miki , Ken-ichi Naruo , Hideki Takahashi
IPC分类号: C07C259/06 , C07D215/14 , C07D215/20 , C07D217/14 , C07D235/16 , C07D263/56 , C07D277/64 , C07D513/04 , A61K31/165
CPC分类号: C07D263/56 , C07C259/06 , C07D215/14 , C07D215/20 , C07D217/14 , C07D235/16 , C07D277/64 , C07D513/04
摘要: The present invention relates to a compound of the formula: ##STR1## wherein Ar represents an optionally substituted aromatic group; Q represents a divalent aliphatic hydrocarbon group; R.sub.1 represents hydrogen, cyano, an optionally substituted hydrocarbon group, a group of the formula: ##STR2## wherein R.sup.3 and R.sub.4 independently represent hydrogen, acyl or an optionally substituted hydrocarbon group, or R.sup.3 and R.sup.4 jointly form a ring, or acyl; R.sup.2 represents acyl; ......... represents a single bond or a double bond; m represents 1 or 2 or a salt, a process of producing thereof and an anti-neurodegenerative composition.
摘要翻译: 本发明涉及下式的化合物:其中Ar表示任选取代的芳族基团; Q表示二价脂族烃基; R 1表示氢,氰基,任选取代的烃基,下式的基团:其中R 3和R 4独立地表示氢,酰基或任选取代的烃基,或者R 3和R 4共同形成环或酰基; R2代表酰基; + E,ovs ......... + EE表示单键或双键; m表示1或2或其盐,其制备方法和抗神经变性组合物。
-
公开(公告)号:US5891916A
公开(公告)日:1999-04-06
申请号:US662240
申请日:1996-06-14
IPC分类号: C07C259/06 , C07C271/60 , C07D277/30 , C07C239/08 , A61K31/19 , C07D277/00
CPC分类号: C07C271/60 , C07C259/06
摘要: A compound represented by the formula: ##STR1## wherein Ar.sup.1 and Ar.sup.2 independently represent an optionally substituted aromatic group; Q represents an optionally substituted divalent aliphatic hydrocarbon group optionally containing O or S; R.sup.1 represents H, acyl group, etc.; and X represents an electron-withdrawing group, an optionally substituted aromatic group, a group of the formula: ##STR2## wherein R.sup.2 and R.sup.3 independently represent H, acyl group or an optionally substituted hydrocarbon group, etc., etc.; or salts thereof are useful as an excellent anti-neurodegenerative agent.
摘要翻译: 由下式表示的化合物:其中Ar 1和Ar 2独立地表示任选取代的芳基; Q表示任选含有O或S的任选取代的二价脂族烃基; R1代表H,酰基等; X表示吸电子基团,可以具有取代基的芳基,下式的基团:其中R2和R3独立地表示H,酰基或任意取代的烃基等; 或其盐可用作优异的抗神经变性剂。
-
公开(公告)号:US07495018B2
公开(公告)日:2009-02-24
申请号:US10239692
申请日:2001-03-29
IPC分类号: A61K31/4436 , C07D417/04
CPC分类号: C07D417/04
摘要: (1) A 1,3-thiazole compound of which the 5-position is substituted with a 4-pyridyl group having a substituent including no aromatic group or (2) a 1,3-thiazole compound of which the 5-position is substituted with a pyridyl group having at the position adjacent to a nitrogen atom of the pyridyl group a substituent including no aromatic group has an excellent p38 MAP kinase inhibitory activity.
摘要翻译: (1)5-取代的不具有芳香族基团的取代基的4-吡啶基的1,3-噻唑化合物或(2)取代有5位的1,3-噻唑化合物 在与吡啶基的氮原子相邻的位置具有吡啶基的情况下,不含芳香族基团的取代基具有优异的p38MAP激酶抑制活性。
-
公开(公告)号:US20050080113A1
公开(公告)日:2005-04-14
申请号:US10480551
申请日:2002-06-10
IPC分类号: A61K31/00 , A61P29/00 , A61P43/00 , C07D417/04 , C07D417/14 , A61K31/426 , A61K31/4439
CPC分类号: C07D417/04 , A61K31/00 , C07D417/14
摘要: The present invention relates to an agent for the prophylaxis or treatment of pain, an agent for suppressing activation of osteoclast, and an inhibitor of osteoclast formation, which contains a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor.
摘要翻译: 本发明涉及含有p38 MAP激酶抑制剂和/或TNF-α产生抑制剂的用于预防或治疗疼痛的药剂,用于抑制破骨细胞活化的药剂和破骨细胞形成抑制剂。
-
公开(公告)号:US5622928A
公开(公告)日:1997-04-22
申请号:US593535
申请日:1996-01-24
申请人: Ken-ichi Naruo , Chisako Seko , Tsutomu Kurokawa , Tatsuya Kondo
发明人: Ken-ichi Naruo , Chisako Seko , Tsutomu Kurokawa , Tatsuya Kondo
IPC分类号: A61K38/00 , A61P25/00 , A61P43/00 , C07K14/00 , C07K14/47 , C07K14/475 , C07K14/52 , C12N1/21 , C12N5/10 , C12N15/09 , C12N15/12 , C12P21/02 , C12R1/19 , C12R1/91 , A61K38/18
CPC分类号: C07K14/4756 , C07K14/475 , A61K38/00
摘要: Disclosed are (1) a novel glia activating factor which has glial cell growth promoting activity; (2) a glia activating factor containing a polypeptide; (3) a DNA coding for a glia activating factor; (4) a host transformed with a vector containing the DNA and (5) a method for producing the above glia activating factor which comprises cultivating the transformant described in a medium, accumulating the glia activating factor in a culture broth, and collecting the resulting glia activating factor.
摘要翻译: 公开了(1)具有神经胶质细胞生长促进活性的新型神经胶质激活因子; (2)含有多肽的胶质激活因子; (3)编码神经胶质激活因子的DNA; (4)用含有DNA的载体转化的宿主(5)上述胶原激活因子的制造方法,其特征在于,培养介质中记载的转化体,在培养液中积聚神经胶质细胞活化因子,收集所得到的胶质细胞 激活因子。
-
-
-
-
-
-
-